Literature DB >> 96137

Quantitative influence of antibody and complement coating of red cells on monocyte-mediated cell lysis.

R J Kurlander, W F Rosse, G L Logue.   

Abstract

Monocyte-mediated lysis in vitro of human red cells coated with measured amounts of immunoglobulin G (IgG) or complement were studied. 1,000-1,500 molecules of IgG anti-D are necessary to effect measurable lysis, and lysis increases linearly with increasing levels of antibody sensitization. 100 microgram/ml of IgG1 abolished lysis even at maximal levels of anti-D sensitization (15,000 molecules/cell). Two isoimmune IgG anti-A or anti-B antisera were 5 to 10-fold less efficient in promoting phagocytosis or lysis per molecule of IgG bound; however, because of the greater antigen density of A or B, more than 100,000 molecules IgG/cell could be bound, producing equivalent lysis to anti-D-coated cells. Although inhibition by IgG1 was similar at equivalent levels of sensitization with anti-A, anti-B, or anti-D at high levels of coating with anti-A or anti-B (not attainable with anti-D), lysis was not inhibited by IgG1. Cells coated with human complement components alone were not lysed by monocytes; however, complement coating augmented IgG-mediated lysis and reduced the quantity of anti-D necessary to produce lysis to less than 1,000 molecules/cell. After thorough degradation of C3b by serum to C3d, complement augmentation persisted.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 96137      PMCID: PMC372653          DOI: 10.1172/JCI109048

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  Coombs--negative immune hemolytic anemia.

Authors:  B C Gilliland
Journal:  Semin Hematol       Date:  1976-10       Impact factor: 3.851

2.  Immunologic mechanisms in autoimmune hemolytic disease.

Authors:  G Logue; W Rosse
Journal:  Semin Hematol       Date:  1976-10       Impact factor: 3.851

3.  Haemolytic activity of human blood monocytes. Lysis of human erythrocytes treated with anti-A serum.

Authors:  G Holm; S Hammarström
Journal:  Clin Exp Immunol       Date:  1973-01       Impact factor: 4.330

4.  Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G.

Authors:  H Huber; M J Polley; W D Linscott; H H Fudenberg; H J Müller-Eberhard
Journal:  Science       Date:  1968-12-13       Impact factor: 47.728

5.  Monocyte-mediated antibody-dependent cellular cytotoxicity: a clinical test of monocyte function.

Authors:  D G Poplack; G D Bonnard; B J Holiman; R M Blaese
Journal:  Blood       Date:  1976-12       Impact factor: 22.113

6.  Quantitative immunology of immune hemolytic anemia: II. The relationship of cell-bound antibody to hemolysis and the effect of treatment.

Authors:  W F Rosse
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

7.  Red cells coated with immunoglobulin G: binding and sphering by mononuclear cells in man.

Authors:  A F LoBuglio; R S Cotran; J H Jandl
Journal:  Science       Date:  1967-12-22       Impact factor: 47.728

8.  Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation.

Authors:  C Bianco; F M Griffin; S C Silverstein
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

9.  Specificity of human lymphocyte complement receptors.

Authors:  G D Ross; M J Polley
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

10.  Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b.

Authors:  G D Ross; M J Polley; E M Rabellino; H M Grey
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

View more
  19 in total

Review 1.  The pathology of autoimmune haemolytic anaemia.

Authors:  R J Sokol; D J Booker; R Stamps
Journal:  J Clin Pathol       Date:  1992-12       Impact factor: 3.411

2.  Small quantities of erythrocyte bound immunoglobulins and autoimmune haemolysis.

Authors:  R J Sokol; S Hewitt; D J Booker; R Stamps
Journal:  J Clin Pathol       Date:  1987-03       Impact factor: 3.411

3.  The functional activity of human monocytes passively sensitized with monoclonal anti-D suggests a novel role for Fc gamma RI in the immune destruction of blood cells.

Authors:  H L Griffiths; B M Kumpel; C J Elson; A G Hadley
Journal:  Immunology       Date:  1994-11       Impact factor: 7.397

4.  Interactions between soluble IgG, complement and cells in lymphocyte and monocyte ADCC.

Authors:  R N Poston; R S Morgan
Journal:  Immunology       Date:  1983-11       Impact factor: 7.397

5.  Antibody-dependent cellular cytotoxicity with platelets as the target cell: potential application to the study of immune thrombocytopenia.

Authors:  N Gengozian; D T Rice
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

6.  Effect of diethyldithiocarbamate (DDC) on human monocyte function and metabolism.

Authors:  P Conkling; D G Cornwell; A L Sagone
Journal:  Inflammation       Date:  1985-06       Impact factor: 4.092

7.  Proteoglycans, proteases, chemotaxis, and aggregation of inflammatory, cells.

Authors:  W S Lynn; C Mukherjee
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

8.  Human monocyte antibody-dependent cell-mediated cytotoxicity to tumor cells.

Authors:  G M Shaw; P C Levy; A F LoBuglio
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

9.  Activation of monocyte and granulocyte antibody-dependent cytotoxicity by phorbol myristate acetate.

Authors:  D K Klassen; P R Conkling; A L Sagone
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

10.  Factors affecting severity of injury during nephrotoxic nephritis in rabbits.

Authors:  R Van Zyl Smit; A J Rees; D K Peters
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.